Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Bexxar: encouraging interim phase III data reported

May 14, 1998

DAB389IL-7, a novel fusion protein for the specific elimination of IL-7 receptor-positive cells

May 12, 1998

Patient enrollment begins for U.S. trial of Maxamine in malignant melanoma

May 11, 1998

Multikine clinical trials update

May 11, 1998

Genentech files for marketing approval of Herceptin

May 5, 1998

Biomira initiates bridging study of Theratope cancer vaccine

May 4, 1998

Efficacy of StressGen's HspE7 in preclinical cancer models reported at FASEB 98

April 28, 1998

Cytokine Networks to initiate clinical trial of anticancer vaccine

April 24, 1998

Schering-Plough seeks FDA approval for Intron A combination

April 20, 1998

Mechanism of cytotoxic effect of ImmTher

April 9, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...